La Monica, G.; Bono, A.; Alamia, F.; Tocco, D.; Pizzolanti, G.; Lauria, A.; Martorana, A.
Imidazole-Functionalized Thieno[3,2-c]Quinoline Hybrids in Aggressive Medullary Thyroid Cancer Cell Models: Biological Evaluation and in Silico Insights. Pharmaceuticals 2026, 19, 1037.
https://doi.org/10.3390/ph19071037
AMA Style
La Monica G, Bono A, Alamia F, Tocco D, Pizzolanti G, Lauria A, Martorana A.
Imidazole-Functionalized Thieno[3,2-c]Quinoline Hybrids in Aggressive Medullary Thyroid Cancer Cell Models: Biological Evaluation and in Silico Insights. Pharmaceuticals. 2026; 19(7):1037.
https://doi.org/10.3390/ph19071037
Chicago/Turabian Style
La Monica, Gabriele, Alessia Bono, Federica Alamia, Dennis Tocco, Giuseppe Pizzolanti, Antonino Lauria, and Annamaria Martorana.
2026. "Imidazole-Functionalized Thieno[3,2-c]Quinoline Hybrids in Aggressive Medullary Thyroid Cancer Cell Models: Biological Evaluation and in Silico Insights" Pharmaceuticals 19, no. 7: 1037.
https://doi.org/10.3390/ph19071037
APA Style
La Monica, G., Bono, A., Alamia, F., Tocco, D., Pizzolanti, G., Lauria, A., & Martorana, A.
(2026). Imidazole-Functionalized Thieno[3,2-c]Quinoline Hybrids in Aggressive Medullary Thyroid Cancer Cell Models: Biological Evaluation and in Silico Insights. Pharmaceuticals, 19(7), 1037.
https://doi.org/10.3390/ph19071037
